FDA

Jul 25, 2025 09:01AM

Jul 25, 2025 09:00AM

Jul 25, 2025 08:52AM

Jul 25, 2025 08:34AM

Jul 25, 2025 08:00AM

Jul 25, 2025 07:22AM

Jul 25, 2025 07:15AM Ionis drug TRYNGOLZA gets EU committee approval recommendation for rare disease

Jul 25, 2025 06:50AM

Jul 25, 2025 06:28AM

Jul 25, 2025 06:27AM

Jul 25, 2025 05:58AM

Jul 25, 2025 02:45AM

Jul 24, 2025 05:43PM

Jul 24, 2025 05:04PM Exelixis partner Ipsen gets EU approval for neuroendocrine tumor treatment

Jul 24, 2025 04:38PM

Jul 24, 2025 04:05PM

Jul 24, 2025 04:01PM

Jul 24, 2025 04:00PM

Jul 24, 2025 02:21PM

Jul 24, 2025 02:00PM

Jul 24, 2025 01:42PM Ipsen wins EU approval for Cabometyx in neuroendocrine tumors

Jul 24, 2025 11:58AM

Jul 24, 2025 09:25AM

Jul 24, 2025 08:15AM

Jul 24, 2025 08:06AM

Jul 24, 2025 08:05AM

Jul 24, 2025 08:01AM

Jul 24, 2025 08:01AM BioVie presents data on bezisterim's biological aging effects

Jul 24, 2025 08:01AM

Jul 24, 2025 08:00AM

Jul 24, 2025 08:00AM

Jul 24, 2025 07:30AM

Jul 24, 2025 07:30AM

Jul 24, 2025 07:00AM

Jul 24, 2025 07:00AM Annexon completes enrollment in phase 3 trial for dry AMD treatment

Jul 24, 2025 07:00AM

Jul 24, 2025 06:45AM

Jul 24, 2025 01:57AM

Jul 23, 2025 12:08PM

Jul 23, 2025 11:39AM

Jul 23, 2025 10:53AM

Jul 23, 2025 10:49AM SK bioscience submits IND for adjuvanted influenza vaccine trial

Jul 23, 2025 10:36AM

Jul 23, 2025 09:42AM

Jul 23, 2025 09:25AM

Jul 23, 2025 09:00AM

Jul 23, 2025 08:45AM

Jul 23, 2025 08:40AM

Jul 23, 2025 08:37AM Harbour BioMed partner starts phase 2 asthma drug trial

Jul 23, 2025 08:33AM

71,324 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.